AIM
Price:
$0.3799
Market Cap:
$1.29M
AIM ImmunoTech Inc., an immuno-pharmaceutical company based in Ocala, Florida, focuses on discovering and advancing treatments for a diverse array of cancers, viral infections, and immune system disorders across the United States. Its primary drug offerings include Ampligen (rintatolimod), a large macromolecular double-stranded ribonucleic acid compound developed for chronic fatigue syndrome, and Alferon N Injection (Interferon alfa), a purified, naturally derived, multi-species alpha interferon prescribed for genital warts. Furthermore, Ampligen is currently undergoing investigation for its potential application in treating pancreatic, renal cell, malignant melanoma, non-small cell lung, ov...[Read more]
Industry
Biotechnology
IPO Date
1995-11-02
Stock Exchange
AMEX
Ticker
AIM
According to AIM ImmunoTech Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.09. This represents a change of -76.50% compared to the average of -0.38 of the last 4 quarters.
The mean historical PE Ratio of AIM ImmunoTech Inc. over the last ten years is -3.29. The current -0.09 PE Ratio has changed 173.60% with respect to the historical average. Over the past ten years (40 quarters), AIM's PE Ratio was at its highest in in the December 2016 quarter at 120.83. The PE Ratio was at its lowest in in the June 2016 quarter at -777.49.
Average
-3.29
Median
-2.04
Minimum
-10.26
Maximum
-0.13
Discovering the peaks and valleys of AIM ImmunoTech Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.79%
Maximum Annual PE Ratio = -0.13
Minimum Annual Increase = -92.18%
Minimum Annual PE Ratio = -10.26
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -0.13 | -92.18% |
| 2024 | -1.68 | -12.36% |
| 2023 | -1.91 | -3.64% |
| 2022 | -1.99 | -66.36% |
| 2021 | -5.90 | -42.47% |
| 2020 | -10.26 | 1.79% |
| 2019 | -0.54 | -74.15% |
| 2018 | -2.10 | -32.93% |
| 2017 | -3.13 | -40.53% |
| 2016 | -5.26 | 52.21% |
The current PE Ratio of AIM ImmunoTech Inc. (AIM) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-1.24
5-year avg
-2.32
10-year avg
-3.29
AIM ImmunoTech Inc.’s PE Ratio is greater than KALA BIO, Inc. (-1.25), less than Oragenics, Inc. (-0.09), greater than Pasithea Therapeutics Corp. (-0.21), greater than VYNE Therapeutics Inc. (-1.31), greater than Quoin Pharmaceuticals, Ltd. (-0.26), less than Ensysce Biosciences, Inc. (-0.08), greater than XTL Biopharmaceuticals Ltd. (-3.99), greater than Alaunos Therapeutics, Inc. (-0.99), greater than Can-Fite BioPharma Ltd. (-685.88), greater than Soligenix, Inc. (-0.20),
| Company | PE Ratio | Market cap |
|---|---|---|
| -1.25 | $79.17M | |
| -0.09 | $2.48M | |
| -0.21 | $3.72M | |
| -1.31 | $10.59M | |
| -0.26 | $9.34M | |
| -0.08 | $2.52M | |
| -3.99 | $6.01M | |
| -0.99 | $5.25M | |
| -685.88 | $1.60M | |
| -0.20 | $4.12M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like AIM ImmunoTech Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like AIM ImmunoTech Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is AIM ImmunoTech Inc.'s PE Ratio?
How is the PE Ratio calculated for AIM ImmunoTech Inc. (AIM)?
What is the highest PE Ratio for AIM ImmunoTech Inc. (AIM)?
What is the 3-year average PE Ratio for AIM ImmunoTech Inc. (AIM)?
What is the 5-year average PE Ratio for AIM ImmunoTech Inc. (AIM)?
How does the current PE Ratio for AIM ImmunoTech Inc. (AIM) compare to its historical average?